
SynBioBeta Speaker
Dan Spellman
Oracle
VP of AI & OCI, Health & Science
Dan serves as Vice President of AI and OCI at Oracle, with responsibility for OCI’s Health & Science organization. This aligns a lifelong love of cutting-edge technology with a passion for applying it to help transform healthcare and save lives. Dan has led OCI's engagements with many of the biggest names in AI, healthcare and life sciences, including collaborations with NVIDIA.
Sessions Featuring
Dan
This Year
•
-
AIxBIO
The New Computational Biology Stack: Models, Compute, and Experimental Feedback
AI is transforming biology into a fully integrated computational discipline, where discovery depends on the seamless interaction between models, compute infrastructure, and experimental systems. As foundation models for proteins, genomes, and cellular systems mature, the challenge is no longer prediction alone. It is building a unified stack that connects generative design, large-scale computation, and rapid experimental feedback into continuous learning loops. This session explores how the next generation of computational biology platforms is emerging at the intersection of cloud computing, GPU-accelerated modeling, advanced simulation, and high-throughput experimental infrastructure. Leaders across AI, biotech, and technology will discuss how tightly integrated design-build-test-learn cycles are reshaping therapeutic discovery, enabling adaptive model refinement, and accelerating the transition from in silico hypotheses to real-world biological outcomes.
•
-
AIxBIO
The New Computational Biology Stack: Models, Compute, and Experimental Feedback
AI is transforming biology into a fully integrated computational discipline, where discovery depends on the seamless interaction between models, compute infrastructure, and experimental systems. As foundation models for proteins, genomes, and cellular systems mature, the challenge is no longer prediction alone. It is building a unified stack that connects generative design, large-scale computation, and rapid experimental feedback into continuous learning loops. This session explores how the next generation of computational biology platforms is emerging at the intersection of cloud computing, GPU-accelerated modeling, advanced simulation, and high-throughput experimental infrastructure. Leaders across AI, biotech, and technology will discuss how tightly integrated design-build-test-learn cycles are reshaping therapeutic discovery, enabling adaptive model refinement, and accelerating the transition from in silico hypotheses to real-world biological outcomes.
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon









































